Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Flammini

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
European Journal of Pharmacology|March 18, 2020
Novel analgesic agents obtained by molecular hybridization of orthosteric and allosteric ligandsCarlo Matera, Lisa Flammini, Fabio Riefolo, et al.
Chemmedchem|June 1, 2010
Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activityMatteo Incerti, Lisa Flammini, Francesca Saccani, et al.
Pharmaceutics|June 26, 2026
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory DiseasesDavide D'Angelo, Stefania Glieca, Lisa Flammini, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 26, 2007
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H3 antagonist ROS203 in rat plasmaFederica Vacondio, Claudia Silva, Alessandro Fioni, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 23, 2008
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activitySimona Bertoni, Vigilio Ballabeni, Lisa Flammini, et al.
European Journal of Pharmacology|February 25, 2023
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axisMarika Allodi, Carmine Giorgio, Matteo Incerti, et al.
European Journal of Medicinal Chemistry|September 8, 2014
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10H-pyrimido[1,2-a][1,8]naphthyridine-6-carboxamide derivativeMario Di Braccio, Giancarlo Grossi, Silvana Alfei, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Effects of CCL20/CCR6 Modulators in a T Cell Adoptive Transfer Model of ColitisMarika Allodi, Lisa Flammini, Carmine Giorgio, et al.
Pharmacological Research|July 12, 2011
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 systemIftiin Hassan Mohamed, Carmine Giorgio, Renato Bruni, et al.
Veterinary Medicine and Science|July 10, 2018
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary studyLisa Flammini, Leonardo Mantelli, Alessandra Volpe, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Pharmacology|March 18, 2020
Novel analgesic agents obtained by molecular hybridization of orthosteric and allosteric ligandsCarlo Matera, Lisa Flammini, Fabio Riefolo, et al.
Chemmedchem|June 1, 2010
Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activityMatteo Incerti, Lisa Flammini, Francesca Saccani, et al.
Pharmaceutics|June 26, 2026
CaP-Coated Cyclosporine A Liposomes Formulated as an Inhalable Dry Powder for Lung Inflammatory DiseasesDavide D'Angelo, Stefania Glieca, Lisa Flammini, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 26, 2007
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H3 antagonist ROS203 in rat plasmaFederica Vacondio, Claudia Silva, Alessandro Fioni, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 23, 2008
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activitySimona Bertoni, Vigilio Ballabeni, Lisa Flammini, et al.
European Journal of Pharmacology|February 25, 2023
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axisMarika Allodi, Carmine Giorgio, Matteo Incerti, et al.
European Journal of Medicinal Chemistry|September 8, 2014
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10H-pyrimido[1,2-a][1,8]naphthyridine-6-carboxamide derivativeMario Di Braccio, Giancarlo Grossi, Silvana Alfei, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Effects of CCL20/CCR6 Modulators in a T Cell Adoptive Transfer Model of ColitisMarika Allodi, Lisa Flammini, Carmine Giorgio, et al.
Pharmacological Research|July 12, 2011
Polyphenol rich botanicals used as food supplements interfere with EphA2-ephrinA1 systemIftiin Hassan Mohamed, Carmine Giorgio, Renato Bruni, et al.
Veterinary Medicine and Science|July 10, 2018
Rifaximin anti-inflammatory activity on bovine endometrium primary cell cultures: a preliminary studyLisa Flammini, Leonardo Mantelli, Alessandra Volpe, et al.
Pageof 5